Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Internal and Emergency Medicine
|
November 3, 2025
24-Month assessment of respiratory function in patients hospitalized for severe SARS-CoV-2 pneumonia: a follow-up study
Laura Pini, Michele Guerini, Jordan Giordani, et al.
Journal of Clinical Medicine
|
October 29, 2025
Osteoporosis in Severe Asthmatic Patients: Data from the Severe Asthma Network in Italy (SANI) Registry
Manuela Latorre, Giulia Costanzo, Andrea Giovanni Ledda, et al.
Journal of Clinical Medicine
|
January 11, 2025
Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma
Francesco Menzella, Mariarita Marchi, Marco Caminati, et al.
Journal of Personalized Medicine
|
February 25, 2025
Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab
Diego Bagnasco, Benedetta Bondi, Luisa Brussino, et al.
Biomedicines
|
February 24, 2024
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective
Marco Caminati, Matteo Maule, Roberto Benoni, et al.
Respiratory Medicine
|
June 13, 2025
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up
Laura Pini, Marco Caminati, Matteo Maule, et al.
Journal of Clinical Medicine
|
May 25, 2024
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
Laura Pini, Diego Bagnasco, Bianca Beghè, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 16, 2025
Profiling Blood Hypereosinophilia in Patients on Dupilumab Treatment for Respiratory Conditions: A Real-Life Snapshot
Marco Caminati, Matteo Maule, Diego Bagnasco, et al.
Biomedicines
|
September 28, 2023
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
Diego Bagnasco, Stefania Nicola, Elisa Testino, et al.
Frontiers in Endocrinology
|
November 8, 2023
Autoimmune polyglandular syndrome type 4: experience from a single reference center
Elisa Gatta, Valentina Anelli, Elena Cimino, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Internal and Emergency Medicine
|
November 3, 2025
24-Month assessment of respiratory function in patients hospitalized for severe SARS-CoV-2 pneumonia: a follow-up study
Laura Pini, Michele Guerini, Jordan Giordani, et al.
Journal of Clinical Medicine
|
October 29, 2025
Osteoporosis in Severe Asthmatic Patients: Data from the Severe Asthma Network in Italy (SANI) Registry
Manuela Latorre, Giulia Costanzo, Andrea Giovanni Ledda, et al.
Journal of Clinical Medicine
|
January 11, 2025
Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma
Francesco Menzella, Mariarita Marchi, Marco Caminati, et al.
Journal of Personalized Medicine
|
February 25, 2025
Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab
Diego Bagnasco, Benedetta Bondi, Luisa Brussino, et al.
Biomedicines
|
February 24, 2024
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective
Marco Caminati, Matteo Maule, Roberto Benoni, et al.
Respiratory Medicine
|
June 13, 2025
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up
Laura Pini, Marco Caminati, Matteo Maule, et al.
Journal of Clinical Medicine
|
May 25, 2024
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
Laura Pini, Diego Bagnasco, Bianca Beghè, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 16, 2025
Profiling Blood Hypereosinophilia in Patients on Dupilumab Treatment for Respiratory Conditions: A Real-Life Snapshot
Marco Caminati, Matteo Maule, Diego Bagnasco, et al.
Biomedicines
|
September 28, 2023
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
Diego Bagnasco, Stefania Nicola, Elisa Testino, et al.
Frontiers in Endocrinology
|
November 8, 2023
Autoimmune polyglandular syndrome type 4: experience from a single reference center
Elisa Gatta, Valentina Anelli, Elena Cimino, et al.
Page
of 7